News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,839 Results
Type
Article (22837)
Company Profile (50)
Press Release (258952)
Section
Business (76160)
Career Advice (722)
Deals (11442)
Drug Delivery (46)
Drug Development (39633)
Employer Resources (67)
FDA (6974)
Job Trends (6479)
News (134220)
Policy (12460)
Tag
Academia (2133)
Alliances (23112)
Alzheimer's disease (1035)
Approvals (6950)
Artificial intelligence (121)
Bankruptcy (119)
Best Places to Work (5715)
Breast cancer (135)
Cancer (1046)
Cardiovascular disease (75)
Career advice (626)
Cell therapy (185)
Clinical research (31105)
Collaboration (395)
COVID-19 (1657)
C-suite (90)
Data (975)
Diabetes (97)
Diagnostics (3770)
Earnings (21837)
Employer resources (62)
Events (37887)
Executive appointments (293)
FDA (7515)
Funding (388)
Gene therapy (169)
GLP-1 (252)
Government (2318)
Healthcare (9149)
Infectious disease (1723)
Inflammatory bowel disease (76)
Interviews (102)
IPO (5410)
Job creations (994)
Job search strategy (555)
Layoffs (139)
Legal (1860)
Lung cancer (164)
Lymphoma (68)
Manufacturing (119)
Medical device (5225)
Medtech (5228)
Mergers & acquisitions (6204)
Metabolic disorders (244)
Neuroscience (1302)
NextGen: Class of 2025 (2993)
Non-profit (3067)
Northern California (982)
Obesity (122)
Opinion (122)
Parkinson's disease (78)
Patents (69)
People (26176)
Phase I (10199)
Phase II (14237)
Phase III (9885)
Pipeline (393)
Postmarket research (917)
Preclinical (4609)
Radiopharmaceuticals (107)
Rare diseases (203)
Real estate (2096)
Regulatory (9222)
Research institute (2100)
Resumes & cover letters (92)
Series A (62)
Southern California (856)
Startups (1728)
United States (9055)
Vaccines (326)
Weight loss (65)
Date
Today (2)
Last 7 days (297)
Last 30 days (1297)
Last 365 days (17291)
2025 (2312)
2024 (17498)
2023 (19697)
2022 (24537)
2021 (27152)
2020 (26274)
2019 (21551)
2018 (16025)
2017 (14303)
2016 (13532)
2015 (15566)
2014 (11120)
2013 (9091)
2012 (9441)
2011 (9667)
2010 (8115)
Location
Africa (331)
Arizona (72)
Asia (16104)
Australia (3389)
California (2261)
Canada (709)
China (173)
Colorado (108)
Connecticut (102)
Europe (36469)
Florida (359)
Georgia (62)
Illinois (233)
Indiana (109)
Maryland (348)
Massachusetts (1741)
Michigan (75)
Minnesota (120)
New Jersey (729)
New York (745)
North Carolina (376)
Northern California (982)
Ohio (109)
Pennsylvania (525)
South America (418)
Southern California (856)
Texas (416)
Utah (84)
Washington State (206)
281,839 Results for "critical path institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
Critical Path Institute and Centogene N.V. are pleased to announce the signing of a Memorandum of Understanding to advance drug development for lysosomal diseases and improve the quality of life for those impacted by these conditions.
June 20, 2024
·
5 min read
Press Releases
Etiometry Launches ADK 2.0 to Support Critical Care Researchers with a Quick Path to Design and Deploy Custom Algorithms to Translate Outcomes Data into Practice
December 12, 2024
·
3 min read
C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research
Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for potential therapies for Duchenne muscular dystrophy (DMD).
March 28, 2024
·
4 min read
Press Releases
Bio-Path Holdings Expands Global Patent Portfolio
February 14, 2025
·
4 min read
Press Releases
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients
February 12, 2025
·
3 min read
Press Releases
Bio-Path Holdings Provides Key Clinical Updates
February 14, 2025
·
6 min read
Business
C-Path Appoints Dr. Klaus Romero as New CEO
Critical Path Institute announced that Klaus Romero, M.D., M.S., FCP, has been named its new Chief Executive Officer.
January 9, 2024
·
4 min read
Gene Therapy
Vertex, CRISPR’s Casgevy Highlights Complex Path to Gene Therapy Profitability
No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy. Experts weigh in on the path to profit for the treatment and the therapeutic class in general.
September 11, 2024
·
7 min read
·
Annalee Armstrong
Press Releases
Bio-Path Holdings Provides 2025 Clinical and Operational Update
January 13, 2025
·
9 min read
Cancer
Pfizer Sees Path to Braftovi’s Full Approval With Phase III CRC Data
Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the way for its full approval for the treatment of certain colorectal cancers, according to the company.
February 3, 2025
·
2 min read
·
Tristan Manalac
1 of 28,184
Next
